Illumina Ventures

www.illuminaventures.com

VCMatch tracks Illumina Ventures as an investor focused on Biotech, Medtech, and Healthtech companies, Pre-Seed and Seed rounds, and United States, San Francisco Bay Area, and Cambridge markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A

Focus Areas

Biotech, Medtech, Healthtech

Geography

United States, San Francisco Bay Area, and Cambridge

Investment Thesis

Illumina Ventures is the leader in genomics and precision health investing, focused on building the ecosystem and translating investment into innovation to accelerate impact on human health. They operate as true partners to entrepreneurs developing breakthrough science and technology into market-leading companies, leveraging deep technical and entrepreneurial expertise combined with a strategic relationship with Illumina (NASDAQ: ILMN) to identify and build companies that will transform healthcare.

Is Illumina Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Illumina Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Healthtech, and Digital Health, especially across United States, San Francisco Bay Area, and Cambridge.

Focus statement

Premier genomics and precision health venture firm supporting early-stage companies to improve human health through ecosystem building and innovation acceleration across the full spectrum from life sciences tools to therapeutics and digital health.

Value Add

Independently managed with decades of domain expertise and strong operating experience
Strategic relationship with Illumina (NASDAQ: ILMN) providing unique advantages
Illumina Ventures Labs offering provides capital, sequencing, mentorship, and fully equipped genomics lab capabilities
Flexible financing model combining cash and in-kind investment tailored to company milestones
Deep technical expertise with Chief Scientist, Chief AI Scientist, and multiple PhDs on investment team
Access to sequencing technology and proprietary Illumina resources for portfolio companies